Streetbeat News

Earnings

SYRA

Syra Health reported its FY23 earnings with an EPS of $(0.60) compared to $(0.70) the previous year. Revenue slightly decreased to $5.5M from $5.6M YoY. Notably, business units excluding Healthcare Workforce grew by 250%, and Population Health and Digital Health saw significant revenue increases. Gross profit margin improved to 25.6% from 18.9%, and the company ended the year with $3.3M in cash and no long-term debt.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:47 pm

KLG

LWAY

SEED

TBBB

TSN

As of March 25, 2024, five consumer staples stocks are considered overbought based on their RSI values, indicating potential short-term performance issues. Lifeway Foods, BBB Foods, Origin Agritech, WK Kellogg, and Tyson Foods have all seen significant price gains recently, but their high RSI values suggest they may be due for a correction.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 12:47 pm

ATXS

Astria Therapeutics shares surged following the announcement of positive initial proof-of-concept results from the ALPHA-STAR Phase 1b/2 clinical trial for STAR-0215 in HAE patients.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:43 pm

INDP

Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced that it will present new data on its Decoy platform at the AACR Annual Meeting, demonstrating the platform's ability to activate multiple immune cell types for anti-tumor responses. The data, supporting the efficacy of Decoy10 and Decoy20 for cancer treatment, will be detailed in a poster session by Dr. Michael Newman. The findings are significant for advancing the treatment of solid tumors with the Decoy platform.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:41 pm

AEHR

Aehr Test Systems reported preliminary Q3 and FY24 adjusted EPS and revenue results that fell below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:38 pm

LUCY

Innovative Eyewear Inc. (NASDAQ: LUCY) reported a 75% increase in FY23 revenue, reaching $1,152,479 from $659,788 YoY. Q4 2023 sales hit a record $615,754, marking the fourth consecutive quarter of growth. Despite this, the net loss widened to $6,663,428 from $5,681,833 due to operational scale-up. The company attributes growth to direct-to-consumer and Amazon sales, and anticipates further growth with the launch of new smart eyewear lines in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:36 pm

LITB

LightInTheBox Holding Co., Ltd. (NYSE:LITB) reported a 13.3% decline in Q4 FY23 sales year-on-year, with a decrease in product sales and a slight increase in services and others sales. The company's gross margin expanded, but gross profit fell. Operating expenses decreased, and the operating loss remained flat. Adjusted EBITDA improved slightly, and loss per ADS decreased significantly. LITB also disclosed receiving an NYSE non-compliance letter and provided a Q1 2024 revenue outlook of $70 million to $80 million. Shares closed higher by 4.94% at $0.7929.

Portfolio Pulse from Shivani Kumaresan

March 25, 2024 | 12:28 pm

ZVSA

ZyVersa Therapeutics reported a Fiscal Year 2023 Earnings Per Share (EPS) of $(108.97), indicating a significant loss.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:26 pm

CMG

CNM

MU

NVDA

SHAK

Wall Street's most accurate analysts have made new stock picks, highlighting potential upsides and downsides in companies like Micron Technology, NVIDIA, Shake Shack, Core & Main, and Chipotle Mexican Grill. These picks are based on recent company performances and market trends, with analysts from firms like Oppenheimer, Truist Securities, Wedbush, Deutsche Bank, and Wells Fargo providing insights.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 12:23 pm

ARTL

Artelo Biosciences reported its FY23 financial results, showing an EPS of $(3.14) compared to $(3.56) YoY. The company's cash and investments stood at $10.4 million, with R&D expenses at $5.7 million and G&A expenses at $4.2 million. The net loss for the year was $9.3 million, an improvement from the previous year's $10.1 million.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:20 pm